-
Je něco špatně v tomto záznamu ?
Androgenetic alopecia and polymorphism of the androgen receptor gene (SNP rs6152) in patients with benign prostate hyperplasia or prostate cancer
R. Kucerova, M. Bienova, M. Kral, J. Bouchal, KS. Trtkova, A. Burdova, V. Student, Z. Kolar,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NT11201
MZ0
CEP - Centrální evidence projektů
PubMed
24665929
DOI
10.1111/jdv.12468
Knihovny.cz E-zdroje
- MeSH
- alely MeSH
- alopecie krev komplikace genetika MeSH
- androgenní receptory genetika MeSH
- dospělí MeSH
- hyperplazie prostaty krev komplikace genetika MeSH
- jednonukleotidový polymorfismus MeSH
- karcinom krev komplikace genetika MeSH
- lidé středního věku MeSH
- lidé MeSH
- nádory prostaty krev komplikace genetika MeSH
- prostatický specifický antigen krev MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- stupeň závažnosti nemoci MeSH
- testosteron krev MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
BACKGROUND: Both androgenetic alopecia (AGA) and carcinoma of the prostate (CaP) or benign prostatic hyperplasia (BPH) are androgen-dependent disorders. OBJECTIVE: To investigate the relationships between male androgenetic alopecia, androgen receptor (AR) gene polymorphism (SNP rs6152) and clinical characteristics of BPH and prostate cancer. METHODS: Overall, 309 male subjects with prostate disease (BPH or CaP) were examined. We evaluated the standard grades of AGA (I-VII) by Hamilton-Norwood classification and 195 patients were also assessed by phototrichogram. Prostate-specific antigen (PSA) and testosterone levels were also measured. Polymorphism rs6152 of the AR was evaluated from blood samples by PCR-RFLP. Data were statistically evaluated. RESULTS: The expected positive correlation between age and AGA grade and the expected negative correlation between hair density and age and between anagen/telogen and AGA were found. A statistically significant difference between patients with A and G alleles in terms of AGA grade was found. The predominant G allele was more frequent in patients with higher grade of alopecia and in patients with significantly higher PSA. There was no correlation between diagnosis (BPH or CaP) and polymorphism. Patients with prostate inflammation had a statistically significant higher grade of AGA, together with higher PSA. CONCLUSIONS: We confirmed that the AR gene polymorphism (SNP rs6152 G>A) is associated with the development of AGA and higher PSA levels in patients with BPH but not cancer. A novel finding of our study is that BPH patients with prostate inflammation had a significantly higher grade of AGA together with significantly higher PSA levels.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16000783
- 003
- CZ-PrNML
- 005
- 20170412141337.0
- 007
- ta
- 008
- 160108s2015 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/jdv.12468 $2 doi
- 035 __
- $a (PubMed)24665929
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Kučerová, Renata, $u Department of Dermatovenereology, Faculty of Medicine and Dentistry, Palacký University and University Hospital, Olomouc, Czech Republic $d 1960- $7 stk2008428616
- 245 10
- $a Androgenetic alopecia and polymorphism of the androgen receptor gene (SNP rs6152) in patients with benign prostate hyperplasia or prostate cancer / $c R. Kucerova, M. Bienova, M. Kral, J. Bouchal, KS. Trtkova, A. Burdova, V. Student, Z. Kolar,
- 520 9_
- $a BACKGROUND: Both androgenetic alopecia (AGA) and carcinoma of the prostate (CaP) or benign prostatic hyperplasia (BPH) are androgen-dependent disorders. OBJECTIVE: To investigate the relationships between male androgenetic alopecia, androgen receptor (AR) gene polymorphism (SNP rs6152) and clinical characteristics of BPH and prostate cancer. METHODS: Overall, 309 male subjects with prostate disease (BPH or CaP) were examined. We evaluated the standard grades of AGA (I-VII) by Hamilton-Norwood classification and 195 patients were also assessed by phototrichogram. Prostate-specific antigen (PSA) and testosterone levels were also measured. Polymorphism rs6152 of the AR was evaluated from blood samples by PCR-RFLP. Data were statistically evaluated. RESULTS: The expected positive correlation between age and AGA grade and the expected negative correlation between hair density and age and between anagen/telogen and AGA were found. A statistically significant difference between patients with A and G alleles in terms of AGA grade was found. The predominant G allele was more frequent in patients with higher grade of alopecia and in patients with significantly higher PSA. There was no correlation between diagnosis (BPH or CaP) and polymorphism. Patients with prostate inflammation had a statistically significant higher grade of AGA, together with higher PSA. CONCLUSIONS: We confirmed that the AR gene polymorphism (SNP rs6152 G>A) is associated with the development of AGA and higher PSA levels in patients with BPH but not cancer. A novel finding of our study is that BPH patients with prostate inflammation had a significantly higher grade of AGA together with significantly higher PSA levels.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a alely $7 D000483
- 650 _2
- $a alopecie $x krev $x komplikace $x genetika $7 D000505
- 650 _2
- $a karcinom $x krev $x komplikace $x genetika $7 D002277
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a jednonukleotidový polymorfismus $7 D020641
- 650 _2
- $a prostatický specifický antigen $x krev $7 D017430
- 650 _2
- $a hyperplazie prostaty $x krev $x komplikace $x genetika $7 D011470
- 650 _2
- $a nádory prostaty $x krev $x komplikace $x genetika $7 D011471
- 650 _2
- $a androgenní receptory $x genetika $7 D011944
- 650 _2
- $a stupeň závažnosti nemoci $7 D012720
- 650 _2
- $a testosteron $x krev $7 D013739
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Bienová, Martina, $d 1965- $7 stk2008428617 $u Department of Dermatovenereology, Faculty of Medicine and Dentistry, Palacký University and University Hospital, Olomouc, Czech Republic
- 700 1_
- $a Král, Milan $7 xx0079094 $u Department of Urology, Faculty of Medicine and Dentistry, Palacký University and University Hospital, Olomouc, Czech Republic
- 700 1_
- $a Bouchal, Jan, $d 1973- $7 xx0034399 $u Department of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacký University and University Hospital, Olomouc, Czech Republic
- 700 1_
- $a Smešný Trtková, Kateřina, $d 1965- $7 xx0143535 $u Department of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacký University and University Hospital, Olomouc, Czech Republic
- 700 1_
- $a Burdova, A $u Department of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacký University and University Hospital, Olomouc, Czech Republic; Department of Cytogenetocs, Laboratory of Medical Genetics, AGEL Laboratories, AGEL Research and Training Institute, Nový Jičín, Czech Republic
- 700 1_
- $a Študent, Vladimír $u Department of Urology, Faculty of Medicine and Dentistry, Palacký University and University Hospital, Olomouc, Czech Republic
- 700 1_
- $a Kolář, Zdeněk, $d 1953- $7 jn20000710256 $u Department of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacký University and University Hospital, Olomouc, Czech Republic
- 773 0_
- $w MED00002983 $t Journal of the European Academy of Dermatology and Venereology JEADV $x 1468-3083 $g Roč. 29, č. 1 (2015), s. 91-96
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/24665929 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160108 $b ABA008
- 991 __
- $a 20170412141637 $b ABA008
- 999 __
- $a ok $b bmc $g 1103064 $s 924989
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 29 $c 1 $d 91-96 $e 20140325 $i 1468-3083 $m Journal of the European Academy of Dermatology and Venereology $n J Eur Acad Dermatol Venerol $x MED00002983
- GRA __
- $a NT11201 $p MZ0
- LZP __
- $a Pubmed-20160108